Executives On The Move: Bayer Elects New Chairman, J&J Vision Exec Makes A Change for Eyevance And CureVac Decides On Candidate For Rare Diseases Post
Executive Summary
Bayer AG elects a new chairman, to begin serving at the end of April. US ophthalmic products firm Eyevance Pharma brings on board a former J&J Vision exec as chief commercial officer, and German mRNA company CureVac AG appoints a new head of rare diseases.
You may also be interested in...
Execs On The Move, June 2020
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Executives On The Move: Boehringer Announces US Promotion, Immatics Chooses A CMO And DalCor Pharma Fills C-Suite Commercial Post
Boehringer Ingelheim announces its BI Pharma president to take helm from retiring US country managing director and chief executive officer. Immunotherapeutics developer Immatics Biotechnologies chooses GSK cell therapy head as CMO, and precision medicine firm DalCor Pharmaceuticals picks a chief commercial officer.
Executives On The Move: Clinical Positions Filled At Gilead, Sanifit and Spectrum, And Ferring Pharma US Officer Is Promoted
Anti-viral pharma Gilead Sciences, vascular calcification treatment firm Sanifit and hematology and oncology drug developer Spectrum Pharmaceuticals each select a new VP, clinical development. Also, to oversee its group in the US, multinational Ferring Pharmaceuticals promotes its US chief commercial officer to president.